|

Community Screening Study of Diabetic Retinopathy in Tianjin in 2024

RECRUITINGSponsored by Li Xiaorong
Actively Recruiting
SponsorLi Xiaorong
Started2024-03-28
Est. completion2025-03-28
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06478407

Summary

Through this study, the investigators hope to understand the prevalence and influencing factors of diabetic retinopathy in Tianjin, improve the ability of complication detection and intervention in diabetic patients in primary medical and health institutions, and build a diabetes prevention and treatment network. The investigators should adhere to the policy of prevention first, combined with prevention and control, and explore a diabetes' prevention and control model suitable for our city. Extensive publicity and education should be carried out to improve the awareness of self-management ，improve the screening rate of diabetic retinopathy, and reduce the blindness rate.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

\- 1: Clear awareness, barrier-free communication

2: diabetes

Exclusion Criteria:

* 1: Have left the registered home address

  2: In the last 6 months, you have not lived in your place of residence

  3: Have a serious mental illness

Conditions2

DiabetesDiabetic Retinopathy

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.